Bill > HB263

This bill, the Right To Try Act, aims to provide terminally ill patients in New Mexico with greater access to investigational drugs, biologics, and devices that have completed phase one clinical trials with the FDA but have not yet been approved for general use. The key provisions of the bill include: defining eligible patients, requiring written informed consent from patients, exempting physicians from criminal or civil penalties for recommending or supervising the use of investigational products, mandating reporting of adverse events, allowing manufacturers to provide investigational products at no cost to patients, and clarifying that insurers are not required to cover the costs of investigational treatments or subsequent related symptoms. The bill declares an emergency, indicating the need for immediate effect.

Justice

https://www.nmlegis.gov/Legislation/Legislation?chamber=H&legtype=B&legno=263&year=17